Remove 2003 Remove Drug Development Remove Drug Pricing
article thumbnail

Oncology R&D: the patient insights we’re still missing, and how to catch up

pharmaphorum

The numbers are striking – in just the 13 years following 2003, R&D costs were estimated to have doubled , and with failure rates as high as 90% and time to market stagnating at ~12 years for the past three decades , the R&D innovation need is urgent.